1. Home
  2. CRGO vs CHRS Comparison

CRGO vs CHRS Comparison

Compare CRGO & CHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Freightos Limited Ordinary shares

CRGO

Freightos Limited Ordinary shares

HOLD

Current Price

$2.32

Market Cap

195.4M

Sector

Finance

ML Signal

HOLD

Logo Coherus BioSciences Inc.

CHRS

Coherus BioSciences Inc.

HOLD

Current Price

$1.33

Market Cap

186.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRGO
CHRS
Founded
2012
2010
Country
Spain
United States
Employees
N/A
N/A
Industry
Blank Checks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
195.4M
186.0M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
CRGO
CHRS
Price
$2.32
$1.33
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$4.02
AVG Volume (30 Days)
72.5K
861.2K
Earning Date
11-17-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.34
Revenue
$28,642,000.00
$277,728,000.00
Revenue This Year
$26.59
N/A
Revenue Next Year
$23.43
$67.31
P/E Ratio
N/A
$2.53
Revenue Growth
27.55
152.07
52 Week Low
$1.72
$0.71
52 Week High
$4.42
$1.89

Technical Indicators

Market Signals
Indicator
CRGO
CHRS
Relative Strength Index (RSI) 25.25 48.49
Support Level $2.27 $1.30
Resistance Level $2.72 $1.43
Average True Range (ATR) 0.16 0.08
MACD -0.06 0.01
Stochastic Oscillator 8.42 43.75

Price Performance

Historical Comparison
CRGO
CHRS

About CRGO Freightos Limited Ordinary shares

Freightos Ltd operates as a vendor-neutral booking and payment platform for international freight. Its platform supports supply chain efficiency and agility by enabling real-time procurement of ocean and air shipping across more than ten thousand importers/exporters. forwarders, and dozens of airlines and ocean carriers. WebCargo by Freightos is a freight platform connecting carriers and forwarders in particular an air cargo eBooking platform. Freightos.com is a digital international freight marketplace for importers and exporters for instant pricing, booking, and shipment management. The company operates in two segments-Platform segment and Solutions segment. Geographically, the company operates in Europe, Hong Kong, United States which is majority revenue generator and others.

About CHRS Coherus BioSciences Inc.

Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its strategy is to expand the use of LOQTORZI in NPC and advance the development of new indications for LOQTORZI in combination with both its pipeline candidates as well as its industry partners, driving synergies from proprietary combinations, including first-in-class anticancer agents. Its portfolio includes LOQTORZI, CHS-114, and Casdozokitug.

Share on Social Networks: